ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2: IBD scores and general principles and technical aspects - Summary - MDSpire

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2: IBD scores and general principles and technical aspects

  • By

  • Henit Yanai

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Roger Feakins

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Mariangela Allocca

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Johan Burisch

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Pierre Ellul

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Marietta Iacucci

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Christian Maaser

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Alessandra Zilli

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Nina Zidar

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Rune Wilkens

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Bram Verstockt

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Stephan Vavricka

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Mathieu Uzzan

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Jaap Stoker

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Martina Scharitzer

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • David Rubin

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Francesca Rosini

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Jordi Rimola

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Patrick van Rheenen

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Paula Borralho Nunes

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Kerri Novak

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Nurulamin M Noor

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Olga Maria Nardone

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Cathy Lu

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Uri Kopylov

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Konstantinos Katsanos

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Isabelle de Kock

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Amelia Kellar

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Konstaninos Karmiris

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Giovanni Maconi

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Frederica Furfaro

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Emma Flanagan

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Ann Driessen

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Mallory Chavannes

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Dominik Bettenworth

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Shomron Ben-Horin

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Gauraang Bhatnagar

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Pamela Baldin

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Torsten Kucharzik

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • Stuart Taylor

  • the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • July 31, 2025

  • 0 min

Share

Objective:

To synthesize key advancements and recommendations for the diagnosis and monitoring of inflammatory bowel disease (IBD), focusing on scoring systems and technical considerations, including imaging techniques.

Key Findings:
  • Endoscopy remains the reference standard for assessing disease activity in IBD.
  • Validated clinical indices are recommended for evaluating disease activity at every visit.
  • Numerous endoscopic scoring systems, such as MES, UCEIS, and CDEIS, are widely accepted for assessing disease severity.
  • Intestinal ultrasound (IUS) and magnetic resonance enterography (MRE) are effective in detecting changes in disease activity and should be integrated into monitoring protocols.
Interpretation:

The guidelines advocate for the use of validated scoring systems and imaging techniques to enhance the precision of IBD diagnosis and monitoring, aligning with the principles of precision medicine.

Limitations:
  • No ideal clinical index exists for IBD.
  • Some scoring systems may be time-consuming to calculate.
  • Limited data on rectal assessment and no universally adopted definition of rectal transmural remission.
  • Variability in scoring system application across different clinical settings may affect consistency.
Conclusion:

The integration of validated scoring systems and imaging techniques is crucial for optimizing patient outcomes in IBD management.

Original Source(s)

ECCO-ESGAR-ESP-IBUS Guideline on Diagnostics and Monitoring of Patients with Inflammatory Bowel Disease: Part 2: IBD scores and general principles and technical aspects

  • by Henit Yanai, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Roger Feakins, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Mariangela Allocca, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Johan Burisch, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Pierre Ellul, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Marietta Iacucci, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Christian Maaser, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Alessandra Zilli, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Nina Zidar, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Rune Wilkens, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Bram Verstockt, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Stephan Vavricka, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Mathieu Uzzan, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Jaap Stoker, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Martina Scharitzer, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], David Rubin, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Francesca Rosini, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Jordi Rimola, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Patrick van Rheenen, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Paula Borralho Nunes, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Kerri Novak, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Nurulamin M Noor, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Olga Maria Nardone, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Cathy Lu, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Uri Kopylov, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Konstantinos Katsanos, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Isabelle de Kock, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Amelia Kellar, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Konstaninos Karmiris, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Giovanni Maconi, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Frederica Furfaro, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Emma Flanagan, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Ann Driessen, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Mallory Chavannes, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Dominik Bettenworth, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Shomron Ben-Horin, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Gauraang Bhatnagar, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Pamela Baldin, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Torsten Kucharzik, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO], Stuart Taylor, the European Society of Gastrointestinal and Abdominal Radiology [ESGAR] the European Society of Pathology [ESP] and the International Bowel Ultrasonography Group [IBUS] on behalf of the European Crohn’s and Colitis Organisation [ECCO]

  • July 31, 2025

Related Content

Melatonin-induced restoration of the intestinal mucosal barrier in inflammatory bowel disease via activation of the SIRT1-LKB1-pAMPK axis

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

  • May 12, 2026

  • 7 min
Metabolic and Structural Alterations Linked to Mice's Vulnerability to Primary Echinostoma caproni Infections